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Background: Lower extremity atherosclerosis (LEA) is among the most serious diabetic complications and leads to
non-traumatic amputations. The recently developed dual-source CT (DSCT) and 320- multidetector computed
tomography (MDCT) may help to detect plaques more precisely. The aim of our study was to evaluate the
differences in LEA between diabetic and non-diabetic patients using MDCT angiography.
Methods: DSCT and 320-MDCT angiographies of the lower extremities were performed in 161 patients (60 diabetic
and 101 non-diabetic). The plaque type, distribution, shape and obstructive natures were compared.
Results: Compared with non-diabetic patients, diabetic patients had higher peripheral neuropathy, history of
cerebrovasuclar infarction and hypertension rates. A total of 2898 vascular segments were included in the analysis.
Plaque and stenosis were detected in 681 segments in 60 diabetic patients (63.1%) and 854 segments in 101
non-diabetic patients (46.9%; p <0.05). Regarding these plaques, diabetic patients had a higher incidence of mixed
plaques (34.2% vs. 27.1% for non-diabetic patients). An increased moderate stenosis rate and decreased occlusion
rate were observed in diabetic patients relative to non-diabetic patients (35.8% vs. 28.3%; and 6.6% vs. 11.4%;
respectively). In diabetic patients, 362 (53.2%) plaques were detected in the distal lower leg segments, whereas in
non-diabetic patients, 551 (64.5%) plaques were found in the proximal upper leg segments. The type IV plaque
shape, in which the full lumen was involved, was detected more frequently in diabetic patients than in
non-diabetic patients (13.1% vs. 8.2%).
Conclusion: Diabetes is associated with a higher incidence of plaque, increased incidence of mixed plaques,
moderate stenosis and localisation primarily in the distal lower leg segments. The advanced and non-invasive MDCT
could be used for routine preoperative evaluations of LEA.
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According to statistics from the International Diabetes
Federation [1], the global diabetes prevalence reached
246 million in 2007, more than double the rate from the
previous decade. It has been predicted that by 2025, the
global diabetic patient population will reach 380 million
[2]. Lower extremity atherosclerosis (LEA) is among the* Correspondence: guming18@sina.com
†Equal contributors
1Department of Radiology, Chengdu Military General Hospital, Chengdu,
Sichuan 610083, China
Full list of author information is available at the end of the article
© 2014 He et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.most serious diabetic complications and leads to non-
traumatic amputations [3]. The risk of amputation is
15–46-fold higher among diabetic patients than among
non-diabetic patients [4]. Meanwhile, diabetes is com-
plicated by cerebral vascular disease and coronary heart
disease (CHD); therefore, the mortality of diabetic patients
is significantly increased [5].
LEA is always insidious, and it is very important to con-
duct early and accurate imaging evaluations in diabetic pa-
tients to improve patient outcomes, reduce the amputation
rates and amputation planes and reduce the treatment
costs [6]. Digital subtraction angiography (DSA) is cur-
rently considered the ‘gold standard’ for vascular diseaseThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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same time; however, this technique is invasive, expensive,
requires highly trained surgical staff and is potentially dan-
gerous [7]. Regarding the development of imaging tech-
nologies, multidetector computed tomography (MDCT)
has been widely used for non-invasive vascular imaging
evaluations [8-10]. The recently introduced dual-source
CT (DSCT) and 320-MDCT has been widely used to
evaluate cardiovascular and head and neck vascular le-
sions [11-13]; however, few reports have described their
usefulness for LEA lesions. The purposes of this study
were to explore the application of MDCT angiography for
LEA and evaluate the differences in LEA plaque preva-




From November 2011 to November 2013, we retrospect-
ively observed a total of 60 consecutive diabetic patients
(13 women; mean age, 69.42 ± 11.04 years) and 101 non-
diabetic patients (23 women; mean age, 68.50 ± 13.59 years)
who underwent DSCT and 320-MDCT angiography of the
arteries in both legs. The exclusion criteria included an al-
lergy to the iodine contrast agent, liver, kidney or heart
failure (Creatinine level ≥120 mol/L), pregnancy and leg
amputation. The vascular exclusion criteria included
vascular malformations, poor imaging and a lumen
diameter <1.5 mm.
Baseline demographics and medical history were pro-
vided, such as age, gender, history of diabetes mellitus,
hypertension, CHD, cerebrovasuclar infarction (CI) and
laboratory tests. All subjects provided informed consent,
and the study was approved by the ethics committees of
West China Hospital and Military General Hospital of
Chengdu PLA.
MDCT scanning
Examinations were performed with DSCT (Somatom
Definition; Siemens Medical Solutions, Forchheim, Germany)
(n = 136, from November 2011 to June 2013) at West
China Hospital, and 320-MDCT (Aquilion one, Toshiba
Medical Systems, Tokyo, Japan) (n = 25, from May 2013 to
November 2013) at Military General Hospital of Chengdu
PLA. The scan parameters of DSCT were as follows: tube
voltages, 120 KV and 80 KV; tube currents, 55 mAs and
230 mAs; collimation, 2 × 64 × 0.6 mm; pitch, 0.65; recon-
struction thickness, 0.75 mm and interlayer spacing,
0.4 mm. CT data were acquired in the craniocaudal direc-
tion from the common iliac artery to the plantar plane.
The delay between contrast injection and CT acquisition
was determined using bolus tracking software. A circular
region of interest (ROI) for attenuation measurement was
placed in the common iliac artery; data acquisition wasinitiated as soon as the signal intensity in this ROI reached
a threshold of 100 Hounsfield units (HU). A non-ionic
contrast medium (80–100 mL of iopamidol, 370 mg iod-
ine/mL; Bracco Sine Pharmaceutical Corp. Ltd., Shanghai,
China) was immediately administered, followed by 40 mL
of a saline chaser solution through an 18-gauge intraven-
ous antecubital catheter with a dual-head power injector
(Stellant; Medrad, Indianola, PA, USA) at a flow rate of
6 mL/s. 320-MDCT examination was obtained following
standard protocols similar to DSCT.
Image reconstruction
The images were simultaneously transferred to 3D post-
processing workstation 1 (Syngo-Imaging; Siemens Medical
Solutions, Forchheim, Germany) and workstation 2
(Aquilion one, Toshiba Medical Systems, Tokyo, Japan).
Post-processing reconstruction was performed on the
workstation and incorporated multi-planar reconstruc-
tion (MPR), maximum intensity projection (MIP), volume
rendering (VR) and curved planar reformation (CPR).
Image analysis
The bilateral lower extremity arteries were divided into
18 segments, or 9 per leg; these were the common iliac
artery, internal iliac artery, external iliac artery, femoral
artery, popliteal artery, anterior tibial artery, posterior
tibial artery, peroneal artery and dorsalis pedis artery.
These segments were also divided into 2 categories to
include the upper leg arteries (common iliac artery, in-
ternal iliac artery, external iliac artery and femoral artery)
and lower leg arteries (popliteal artery, anterior tibial ar-
tery, posterior tibial artery, peroneal artery and dorsalis
pedis artery). The plaques were classified as non-calcified
(<50 HU), mixed (60–100 HU) or calcified (>130 HU)
according to the average HU value [14]. Luminal nar-
rowing values were automatically calculated by the soft-
ware. The artery stenosis grade was classified as mild
stenosis (luminal narrowing, <50%), moderate stenosis
(luminal narrowing, 50%–74%), severe stenosis (luminal
narrowing, ≥75%) and occlusion (luminal narrowing,
100%) [15]. The atherosclerosis artery axial plane was
divided into 4 quadrants, and the plaque shapes were
described as type I, <25%; type II, 25–50%; type III, 50–75%
and type IV, 75–100% (Figure 1).
Two experienced radiologists blinded to the diagnostic
indices and each other’s decisions evaluated the recon-
structed images for plaque distribution and properties.
Only in cases of disagreement did the 2 radiologists dis-
cuss a case to reach a decision.
Statistical methods
The clinical information, clinical symptoms, laboratory
tests, number of diseased segments, types and shapes of
plaques and grades of luminal narrowing were analysed
Figure 1 Plaque shapes. A. Normal lumen. B. Type I, <25%; C. Type II, 25–50%; D. Type III, 50–75%; E. Type IV, 75–100%.






Age (years) 68.50 ± 13.59 69.42 ± 11.04 >0.05
Gender (female) 23 (22.8%) 13 (21.7%) >0.05
Smoking 43 (42.6%) 26 (43.3%) >0.05
BMI 21.28 ± 2.9 22.34 ± 4.11 >0.05
Blood glucose (mmol/L) 5.92 ± 1.54 7.98 ± 1.42 0.001
Cholesterol (mmol/L) 3.94 ± 1.09 4.39 ± 1.18 0.017
Triglyceride (mmol/L) 1.33 ± 0.74 1.57 ± 0.74 0.042
HDL-C (mmol/L) 1.14 ± 0.31 1.12 ± 0.24 >0.05
LDL-C (mmol/L) 2.27 ± 0.86 2.52 ± 0.90 >0.05
Creatinine (mmol/L) 83.04 ± 25.53 82.39 ± 31.19 >0.05
Uric acid 311.57 ± 100.07 331.48 ± 105.26 >0.05
Hypertension 53 (52.5%) 42 (70.0%) 0.029
Peripheral neuropathy 22 (21.8%) 25 (41.7%) 0.007
History of CHD 29 (28.7%) 22 (36.7%) >0.05
History of CI 72 (33.7%) 36 (60.0%) 0.001
Note: Data were expressed as n (%) or mean ± S.D.
BMI: body mass index; HDL-C: high density lipoprotein cholesterol; LDL-C: low
density lipoprotein cholesterol. CHD: coronary heart disease; CI: cerebrovasuclar
infarction.
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used to test the normality of the distribution. Continuous
data are given as means ± standard deviations. Continuous
variables such as laboratory tests were expressed as means ±
standard deviations and were compared using Student’s
t-test for unpaired data or the Mann–Whitney two-sample
statistic,as appropriate. Categorical variables such as the
types and shapes of plaques were presented as numbers
(percentages) and were compared using the χ2 test. All
data were analysed using the SPSS 16.0 statistical software
package for Windows XP (SPSS Inc., Chicago, IL, USA). A
p-value of <0.05 was considered statistically significant.
Results
General information
All examinations were successfully completed in all pa-
tients without the occurrence of any complications, and
all examinations were of diagnostic image quality with
good to excellent vessel visibility.
Compared with non-diabetic patients, diabetic patients
had higher peripheral neuropathy, hypertension and his-
tory of CI incidence rates (p < 0.05). The remaining clinical
data and laboratory test results are shown in Table 1.
Plaque type and stenosis degree
A total of 2898 vascular segments were included in the
analysis. Plaque and stenosis were detected in 681 (63.1%)
vessel segments in 60 diabetic patients and 854 (46.9%)
vessel segments in 101 non-diabetic patients (p < 0.001).
There was a statistical difference in plaque type between
diabetic and non-diabetic patients (p < 0.05), and diabetic
patients had a higher incidence of mixed plaques (Figure 2,
Table 2).
Statistical difference was observed in the degree of sten-
osis between the 2 groups (p < 0.05). Compared with non-
diabetic patients, diabetic patients had a higher incidence
of moderate stenosis (35.8% vs. 28.3%) and a lower inci-
dence of occlusion (6.6% vs. 11.4%), as shown in Table 2,
Figure 3.
Plaque distribution and shape
Regarding plaque distribution, 362 (53.2%) plaques were
detected in the distal lower leg segments of diabetic pa-
tients, and there was an increased involvement in the
distal lower leg segments, particularly in the poplitealartery, anterior tibial artery and posterior tibial artery. In
non-diabetic patients, 551 (64.5%) plaques were found in
the proximal upper leg segments. The increased distal
segment involvement in diabetic patients and increased
proximal segment involvement in non-diabetic patients
represented significant differences (p = 0.001; Figure 4).
Extensive plaques were observed in both diabetic and
non-diabetic patients; the plaque shapes were primarily
classified as type II and type III, although the incidence
of type IV, in which the full lumen is involved, was
higher among diabetic patients than among non-diabetic
patients and this difference was statistically significant
(Table 2).
Discussion
LEA is a common complication of diabetes [16,17].
Dormandy et al. [16] reported that the prevalence of LEA
among type 2 diabetic patients was as high as 23.5%. In
our study, there were no significant differences with re-
spect to age, sex, smoking status, and uric acid between
Figure 2 DSCT images of a 56-year-old man with diabetes for
15 years, 1 year of cold feet, show diffuse plaques and stenoses
in both lower extremities. A, Volume-rendered reconstruction
(VRT) after dual energy bone removal displays overview of both
lower extremities with a mild stenosis (white arrow), an occlusion
(blue arrow) and a compensatory artery (white triangle) in the right
femoral artery. B, Maximum intensity projection (MIP) depicts the
overview of plaques and stenosis. C, Both the mild stenosis (white
arrow) and occlusion (blue arrow) are caused by non-calcified
plaque as evidenced using curved planar reformation (CPR).
Table 2 Comparison of plaque and stenosis between
diabetic and non-diabetic patients
Characteristics Non-diabetic Diabetic P
N 854 (46.9%) 681 (63.1%) <0.001
Plaque type 0.007
Non-calcified 217 (25.4%) 144 (21.2%)
Mixed 231 (27.1%) 233 (34.2%)
Calcified 406 (47.5%) 304 (44.6%)
Grade of stenosis <0.001
Mild (<50%) 363 (42.5%) 299 (43.9%)
Moderate (≥50%) 242 (28.3%) 244 (35.8%)
Severe (≥75%) 152 (17.8%) 93 (13.7%)
Occlusion (=100%) 97 (11.4%) 45 (6.6%)
Plaque shape 0.018
Type I < 25% 130 (15.2%) 91 (13.4%)
Type II < 50% 377 (44.2%) 290 (42.6%)
Type III < 75% 277 (32.4%) 211 (30.9%)
Type IV≤ 100% 70 (8.2%) 89 (13.1%)
Note: Data were expressed as n (%).
Figure 3 320-MDCT images of a 62-year-old man with diabetes
for 10 years, intermittent claudication of both lower extremities
for 6 months. A, VRT reflects overview artery tree of lower extremities
with bone remaining, showing diffused stenoses in right femoral
artery. B, VRT image after bone removal depicts a severe (blue
arrow) and diffused mild to moderate stenosis (white arrows) in
right femoral artery. C, All the stenoses are caused by non-calcified
plaques as evidenced using coronal MIP. D, Sagital MIP displays the
severe stenosis (blue arrow), mild to moderate stenoses (white arrows)
in right femoral artery caused by non-calcified plaques.
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history of CI and peripheral neuropathy and hypertension
incidence rates were significantly higher among diabetic
patients, indicating that blood sugar and blood pressure
statuses correlated closely with atherosclerosis develop-
ment. These statuses also explained the more severe
atherosclerotic lesions observed among diabetic patients
relative to non-diabetic patients, a finding that corrobo-
rated relevant reports [18-20].
Our study found that the incidence of LEA was sig-
nificantly higher among diabetic patients than among
non-diabetic patients. In our study, a higher incidence
of mixed plaques was observed in the diabetic group, a
finding that was consistent with previous MDCT-based
studies [21,22]. Rosamond et al. [22] reported that type
2 diabetes often led to the development of multiple ath-
erosclerotic plaques, especially unstable mixed plaques.
Unstable mixed plaques, which feature reduced calcifi-
cation and increased fibrotic and lipid contents, are
more vulnerable and more easily form ulcers and rup-
tures that lead to thrombosis, acute coronary heart syn-
drome and other serious and possibly life-threatening
complications [23].
Artery stenoses were mainly mild to moderate in both
groups. Compared with non-diabetic patients, diabetic
Figure 4 Bar graph demonstrates the main distribution of plaques between diabetic and non-diabetic patients, showing the increased
distal segment involvement in diabetic patients (P = 0.01). ULA = Upper Leg arteries, LLA = Lower leg arteries.
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a lower incidence of occlusion. Diabetes-induced athero-
sclerosis was primarily non-obstructive stenosis. Scholte
et al. [2] evaluated the diabetes-related coronary athero-
sclerotic plaque and morphological statuses using 64-
slice CT and found that approximately 82% of stenoses
in diabetic patients were non-occlusive lesions, in ac-
cordance with our study. Other reports of ultrasound
and CT studies [10,21] indicated that when compared
with those in non-diabetic patients, atherosclerotic pla-
ques in diabetic patients, which were mainly mixed pla-
ques with reduced occlusion, were more unstable and
thus more easily ruptured and thrombosed.
Our study found that the 2 groups differed signifi-
cantly in terms of plaque distribution. Non-diabetic ath-
erosclerosis primarily affected the proximal upper leg
segments. In contrast, an increased involvement in the
distal lower leg segments was observed in diabetic pa-
tients, particularly in the popliteal artery, anterior tibial
artery and posterior tibial artery. Previous studies [24,25]
have supported the finding that diabetes-induced athero-
sclerosis involved the distal segments; in particular, the
distal segment atherosclerosis rate was as high as 58%
among diabetic patients and was accompanied by more
severe stenosis and an increased tendency toward vascular
embolism. It was unclear why atherosclerosis distributions
differed between diabetic and non-diabetic patients. We
speculate that diabetes might alter the arterial remodelling
process, thus resulting in diffusely narrowed arteries
that lack compensatory enlargement, especially in dis-
tal segments.
In our study, we also found that plaque shapes in both
groups were primarily type II and type III. The incidence
of Type IV was higher among diabetic patients than
among non-diabetic patients, indicating more wide-
spread atherosclerosis among diabetic patients. Diabetic-induced atherosclerosis was usually multi-stage and wide-
spread and beaded changes in the distal segments [16,18].
These characteristics might induce relatively more severe
symptoms, a poorer prognosis and a higher amputation
incidence. The more diffuse atherosclerotic burdens in
diabetic patients were likely caused by the increased risk
factors resulting from the metabolic disorders that have
been described to cause atherosclerosis [26,27].
When considering non-invasive imaging, the magnetic
resonance (MR) imaging and ultrasound results should
also be compared. Following the developments in non-
invasive imaging equipment and technology, ultrasound
and MR are increasingly used in examinations of lower
extremity arterial disease [28]. However, ultrasound ana-
lysis is operator-dependent. MR imaging, which features
various imaging protocols and sequences, has a demon-
strated ability to characterise morphological, structural
and compositional features of atherosclerotic plaques
in vivo [29]. However, this method is time-consuming
and cannot be performed on some patients with pace-
makers or stents. MDCT has undergone rapid develop-
ment. In particular, dual-source CT and 320-MDCT have
many advantages relative to conventional MDCT, such as
higher temporal and spatial resolution, radiation dose re-
duction [30], and powerful post-processing capabilities.
This study has the following shortcomings. CT angiog-
raphy has some limitations with respect to accurate deter-
mination of stenoses involving large plaques in distal small
segments. Although the radiation dose provided by DSCT
and 320-MDCT is significantly reduced, multiple inspec-
tions cannot be performed within a short time period.
Conclusion
The incidence of LEA was higher among diabetic patients
than non-diabetic patients. Diabetic atherosclerosis, which
featured a higher incidence of mixed plaque and moderate
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http://www.biomedcentral.com/1471-2261/14/125stenosis, was more extensive in the distal segments and
primarily involved arteries in the lower leg. As an ad-
vanced non-invasive technique, MDCT could provide
good evaluations of LEA plaque types, shapes, distribu-
tions and stenosis characteristics and could therefore
be used for routine preoperative evaluations.
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